2006D-0383 | Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases | |||||||||||||||||||||||
FDA Comment Number : | EC3095 | |||||||||||||||||||||||
Submitter : | Dr. Michael Keefe | Date & Time: | 12/14/2006 11:12:26 | |||||||||||||||||||||
Organization : | Dr. Michael Keefe | |||||||||||||||||||||||
Category : | Individual Consumer | |||||||||||||||||||||||
Issue Areas/Comments | ||||||||||||||||||||||||
GENERAL | ||||||||||||||||||||||||
GENERAL | ||||||||||||||||||||||||
There are serious ethical issues with using any cells from aborted or cloned or harvested embryos as biological starting materials for production of vaccines. As a parent or for myself, I would have to refuse injection of any such derived vaccines. My life is not 'more important' than the life of another human and a unique human life begins at conception. | ||||||||||||||||||||||||